ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Interim Bill Keeps NCI Going Through Oct. 31; “Manual Fr Staging Of Cancer” Now Available

October 21, 1977

ACS Honors Cady, Rimer For Work In Cancer Control.

December 8, 2000

Fermilab Treats 1,000th Patient

August 7, 1981

Karmanos Cancer Center Wins $4.6M From U.S. Army.

September 5, 2008

CMF Studies Show Higher Recurrence for Post-Menopausal Patients – Caldwell

November 12, 1976

News Analysis: Industry’s Accelerated Recovery Initiative May Push Manufacturers Toward Collusion

October 5, 2012